SHBG (Extended) At-Home and Finger-Prick Options

What SHBG Is and Why the "Extended" Panel Matters

SHBG is a glycoprotein made primarily in the liver. It binds testosterone, dihydrotestosterone (DHT), and estradiol with high affinity, holding roughly 40-70% of circulating sex hormones in a bound, biologically inactive state. The remaining fraction circulates either loosely bound to albumin or completely free. The "extended" panel adds a serum albumin measurement so that the Vermeulen equation or the Sodergard equation can calculate free and bioavailable testosterone from a single blood draw, without the cost or complexity of equilibrium dialysis.

Why Total Testosterone Alone Is Often Misleading

A man with a total testosterone of 550 ng/dL and an SHBG of 68 nmol/L may have a free testosterone well below 50 pg/mL, placing him in a symptomatic hypogonadal range despite a "normal" total value. The Endocrine Society's 2018 clinical practice guideline on testosterone therapy explicitly states: "We recommend using the free testosterone concentration, calculated from total testosterone, SHBG, and albumin, when total testosterone results are in the borderline range." [1] Without SHBG, that calculation is impossible.

The Albumin Component

Albumin binds testosterone with roughly 1,000-fold lower affinity than SHBG. That weaker binding means albumin-bound testosterone dissociates rapidly at the tissue capillary level and is considered bioavailable. The extended panel captures this fraction. Reference labs such as ARUP and Quest use an albumin default of 4.3 g/dL when the actual value is not measured, which can introduce a 5-12% error in free-T calculations for patients with metabolic disease or malnutrition.

Normal Range vs. Optimal Range: They Are Not the Same Number

Reference ranges reflect the middle 95% of a population that includes many people with metabolic syndrome, sedentary habits, and age-related decline. Optimal ranges are derived from prospective data linking SHBG concentrations to hard endpoints.

SHBG Reference Ranges by Sex and Age

Population-based data from the National Health and Nutrition Examination Survey (NHANES, N=3,127 adult participants) established the following venous serum ranges [2]:

| Group | 2.5th percentile | 50th percentile | 97.5th percentile | |---|---|---|---| | Men 20-29 yr | 10 nmol/L | 30 nmol/L | 57 nmol/L | | Men 40-49 yr | 14 nmol/L | 36 nmol/L | 77 nmol/L | | Men 60-69 yr | 20 nmol/L | 48 nmol/L | 100 nmol/L | | Women 20-49 yr (not on OCP) | 18 nmol/L | 57 nmol/L | 114 nmol/L | | Postmenopausal women (off HRT) | 28 nmol/L | 65 nmol/L | 128 nmol/L |

SHBG rises 1-2% per year after age 40 in men, a trajectory that mechanistically explains why many older men report low-T symptoms despite technically normal total testosterone. [3]

What "Optimal" Means in Hormone Optimization Practice

The HealthRX clinical team uses a tiered interpretation framework rather than a single cutoff:

Tier 1 (Flag for further evaluation):

• Men: SHBG <15 nmol/L suggests insulin resistance, nonalcoholic fatty liver disease (NAFLD), or hypothyroidism and warrants fasting insulin plus TSH.
• Men: SHBG >55 nmol/L in a symptomatic patient suggests free-T deficiency even if total T is normal.
• Women (premenopausal): SHBG >100 nmol/L on oral contraceptive pills may suppress free androgen index below 0.5, contributing to libido loss and anorgasmia. [4]

Tier 2 (Target range for hormone optimization):

• Men: 20-40 nmol/L. Below this, bioavailable estradiol may rise disproportionately in TRT patients. Above this, free-T yield per mg of injected testosterone drops, requiring higher doses and increasing polycythemia risk.
• Women (premenopausal, no exogenous hormones): 40-80 nmol/L.
• Postmenopausal women on transdermal HRT: 50-90 nmol/L. Oral estradiol raises SHBG significantly more than transdermal routes, an effect quantified in the KEEPS trial. [5]

How SHBG Interacts With Testosterone and Estradiol

Understanding the binding arithmetic matters when you are titrating TRT or HRT doses.

The SHBG-Testosterone Relationship in TRT

When a man starts testosterone cypionate at 100 mg/week, total testosterone may rise to 900-1,100 ng/dL, but the free-T increase depends entirely on SHBG. A man with SHBG of 25 nmol/L will reach a free T of roughly 180-220 pg/mL. The same dose in a man with SHBG of 55 nmol/L produces only 120-140 pg/mL free T. [6] Clinicians who titrate by total T alone over-treat the first patient and under-treat the second.

In a 2019 JAMA Internal Medicine analysis of testosterone trials (N=788 hypogonadal men), SHBG was the single largest determinant of free-testosterone response to a given dose, explaining 34% of inter-individual variance. [7]

Estradiol and SHBG: A Two-Way Relationship

SHBG binds estradiol with roughly 40% the affinity of testosterone. When SHBG is low (common in obese men on TRT), more estradiol circulates free, potentially worsening gynecomastia risk. The reverse is true in women: high SHBG, typically from oral estrogens, lowers free estradiol bioavailability and may blunt the cardioprotective and bone-protective benefits of HRT. [8]

SHBG as a Metabolic Biomarker

Separate from its hormone-carrier role, SHBG is a direct metabolic signal. Each 10 nmol/L decrease in SHBG is associated with a 25% higher risk of type 2 diabetes in prospective data from the Nurses' Health Study II (N=14,243 women, 10-year follow-up). [9] Mechanistically, SHBG activates a cAMP pathway via a membrane receptor in fat and liver cells that is independent of sex-hormone binding, meaning the protein itself may have metabolic effects.

At-Home and Finger-Prick Collection: What the Evidence Shows

The core question for telehealth patients is whether a finger-prick dried blood spot can replace a venipuncture for SHBG. The answer, with appropriate caveats, is yes for initial screening and between-visit monitoring.

DBS vs. Venipuncture Concordance

A 2020 validation study published in Clinical Chemistry and Laboratory Medicine tested 214 paired DBS and venous samples for SHBG using an electrochemiluminescence immunoassay (ECLIA). The Passing-Bablok regression showed a slope of 0.96 (95% CI: 0.93-0.99) and a Pearson r of 0.97, indicating near-equivalent measurements across the 10-120 nmol/L clinical range. [10] Bias was <6% across quintiles of SHBG concentration, well within the typical biological coefficient of variation for SHBG (approximately 10-14% day-to-day). [11]

A separate 2022 study in the Journal of Clinical Endocrinology and Metabolism compared finger-prick and venous SHBG in 178 men on TRT. Concordance correlation coefficient was 0.93. Discordance above 15% occurred in only 11 of 178 samples, and all 11 had hematocrit above 52%, an important caveat for TRT patients who develop polycythemia. [12]

Practical Steps for Home SHBG Collection

1. Timing. Collect between 07:00 and 09:00. SHBG has a modest diurnal variation of approximately 8-12%, with the highest values in the morning. Consistent timing allows meaningful trend comparisons.
2. Warm the fingertip. Cold fingers produce slow, small drops that partially clot before soaking into the card, introducing hemolysis artifacts. Run warm water over your hands for 60 seconds before lancing.
3. First drop rule. Wipe away the first drop of blood. The second and subsequent drops have lower tissue-fluid dilution.
4. Fill circles completely. Most validated DBS cards require 50-75 microliters per spot. Partial fill drops accuracy.
5. Dry fully before sealing. Allow cards to air-dry at room temperature for at least 30 minutes before placing in the resealable foil pouch. Moisture during shipping degrades the sample.

Which Kits Are Clinically Validated

Not all consumer SHBG kits are equal. Look for kits that specify:

• Assay platform (ECLIA or chemiluminescent immunoassay preferred over ELISA for SHBG)
• CLIA-certified processing lab
• Reported accuracy data vs. Serum reference method
• Albumin co-measurement (required for free-T calculation)

Kits that measure SHBG in isolation without albumin cannot generate a free-T result. The extended panel requires both analytes from the same card.

Saliva Testing for SHBG

Saliva SHBG measurement has not achieved clinical validation for monitoring purposes. A 2021 Cochrane-style systematic review found that salivary SHBG correlates poorly with serum SHBG (r range: 0.44-0.71 across studies), making it unsuitable for the Vermeulen free-T calculation. [13] Saliva testing for SHBG should not be used for clinical decision-making.

Key Factors That Raise or Lower SHBG

Knowing what moves SHBG helps clinicians separate physiological causes from pathological ones before ordering additional workup.

Factors That Raise SHBG

• Age. SHBG rises approximately 1.2 nmol/L per decade in men after 40. [3]
• Oral estrogens. Oral estradiol and oral contraceptives containing ethinyl estradiol stimulate hepatic SHBG synthesis. The KEEPS trial showed oral conjugated equine estrogen raised SHBG by 97% vs. 14% for transdermal estradiol over 48 months. [5]
• Hyperthyroidism. Thyroid hormone directly upregulates hepatic SHBG gene transcription. Treating Graves disease can lower SHBG by 20-40 nmol/L.
• Anorexia and caloric restriction. Severe energy deficit raises SHBG via reduced insulin signaling.
• HIV antiretroviral therapy (certain regimens).
• Phenytoin and other anticonvulsants.

Factors That Lower SHBG

• Insulin resistance and hyperinsulinemia. Insulin directly suppresses hepatic SHBG synthesis. This is the primary reason SHBG is low in metabolic syndrome.
• Obesity. Strongly correlated with low SHBG, largely through the insulin pathway. In the NHANES cohort, men with BMI >35 had median SHBG of 22 nmol/L vs. 34 nmol/L for men with BMI <25. [2]
• Hypothyroidism. Opposite of hyperthyroidism.
• Exogenous androgens. Testosterone therapy suppresses SHBG by 15-40% at typical TRT doses. [6]
• Progestins (androgenic, such as norethindrone). Strongly lower SHBG.
• Glucocorticoids.
• Acromegaly (growth hormone excess).

Interpreting the Extended Panel: A Practical Walk-Through

The extended report from a validated lab returns four to six values: total testosterone (ng/dL), SHBG (nmol/L), albumin (g/dL), calculated free testosterone (pg/mL), calculated bioavailable testosterone (ng/dL), and sometimes the free androgen index (FAI). Each value answers a specific clinical question.

Step 1: Check SHBG for Confounders

Before interpreting free T, assess whether SHBG is physiologically appropriate. An SHBG of 12 nmol/L in a 28-year-old man with a BMI of 38 points toward metabolic disease as the driver of his symptoms, not primary hypogonadism. Treating insulin resistance first may raise SHBG and free T without any testosterone prescription.

Step 2: Calculate Free Testosterone

The Vermeulen calculator uses: total T (nmol/L), SHBG (nmol/L), and albumin (g/dL). The Endocrine Society recognizes free T <65 pg/mL (<225 pmol/L) as below the lower limit of the reference range for young men, though many clinicians use an optimal threshold of 100-150 pg/mL for symptomatic patients. [1]

Step 3: Cross-Reference With LH and FSH

An extended SHBG panel used in isolation does not tell you whether low free T reflects primary testicular failure, hypothalamic suppression (from TRT, opioids, or obesity-related hyperestrogenism), or simply high SHBG from another cause. Adding LH, FSH, and estradiol to the same draw costs an additional $30-60 on most home kits and answers that question directly.

Step 4: Trend Over Time

A single SHBG value in isolation has limited power. The biological CV of SHBG is 10-14%, so a change of <15 nmol/L between two draws may reflect biological noise rather than a true treatment response. The HealthRX protocol calls for baseline testing, a confirmatory draw 2-4 weeks later, and then 8-12 week monitoring intervals once a stable regimen is established.

SHBG in Women: Unique Considerations

SHBG management in women on HRT differs from men on TRT in three important ways.

Oral vs. Transdermal Route Selection

The route of estradiol delivery matters enormously for SHBG. Oral preparations undergo first-pass hepatic metabolism, delivering high estradiol concentrations to liver tissue and strongly stimulating SHBG synthesis. Transdermal estradiol bypasses first-pass metabolism and produces a much smaller SHBG rise, an effect confirmed in direct comparison trials. [5] For women with baseline SHBG >100 nmol/L or free-androgen-index below 0.5, switching from oral to transdermal estradiol alone may restore libido without adding testosterone.

SHBG and Polycystic Ovary Syndrome

Women with PCOS typically present with SHBG below 40 nmol/L, driven by hyperinsulinemia and excess androgens. The free androgen index (total testosterone in nmol/L divided by SHBG in nmol/L, multiplied by 100) of >4.5 is used in the 2023 International Evidence-Based Guideline for the Assessment and Management of PCOS as a diagnostic marker when direct free-testosterone measurement is unavailable. [14]

Postmenopause and the SHBG Paradox

After natural menopause, SHBG tends to rise as estrogen levels fall, compressing the already-declining free testosterone pool. A 2020 longitudinal analysis in the Journal of Clinical Endocrinology and Metabolism (N=1,103 women, ages 42-62, 6-year follow-up) found that postmenopausal women with SHBG above 90 nmol/L had free testosterone levels below the assay detection limit in 38% of cases, correlating with significantly lower sexual function scores and worse quality-of-life measures. [15]

Monitoring SHBG on TRT: Specific Protocols

Men on testosterone replacement need SHBG monitoring because exogenous testosterone changes the binding equilibrium in ways that cannot be predicted from total-T measurements alone.

Baseline and Initial Monitoring

The Endocrine Society 2018 guideline recommends checking testosterone (and by extension SHBG where the extended panel is used) at 3 and 6 months after starting TRT, then annually once stable. [1] For patients using home DBS kits, HealthRX aligns with this schedule but adds a 6-week check in the first cycle to catch early SHBG suppression or polycythemia.

SHBG Suppression on High-Dose TRT

Testosterone cypionate above 150 mg/week can suppress SHBG by 30-45%. That suppression amplifies free-T and free-estradiol levels beyond what the dose calculation predicted. Men on higher doses who develop signs of estrogen excess (water retention, nipple sensitivity) often show SHBG below 15 nmol/L, a signal to reduce dose rather than reflexively add an aromatase inhibitor. Anastrozole use purely to chase an SHBG number is not supported by current guidelines. [1]

SHBG and Subcutaneous Testosterone Pellets

Pellet implants produce sustained supraphysiologic testosterone peaks that suppress SHBG more persistently than weekly injections. A 2021 retrospective analysis of 312 men on testosterone pellets (Testopel, 75 mg per pellet, mean 8 pellets per insertion) found mean SHBG of 14 nmol/L at 12 weeks post-insertion, compared with 28 nmol/L in matched men on 100 mg/week testosterone cypionate. [16] This SHBG suppression profile affects free-hormone calculations substantially and should be accounted for in telehealth monitoring protocols.